Back to results
US 2020/0027563 A1Published application
Method of Assessing Risk
AssigneeNeumann Diagnostics, Ltd.
InventorMiklos Nyiri
Life of this patent
Estimating the term…
Abstract
The application relates to a method of assessing the risk of a patient for cervical pre-cancer or cancer, especially where there is no sign of a malignancy.
Claims6
A method of identifying a patient at risk of developing cervical pre-cancer or cervical cancer comprising:
- (a)Measuring the level of methylation of a cervical cancer marker in a sample obtained from the patient;
- and
- (b) Determining the level of risk based on the level of methylation and the patient's age.
The use of the level of methylation of a cervical cancer marker, in combination with a patients age, to determine the level of risk of developing cervical cancer or pre-cancer.
Dependencies are inferred from the claim text.